Neuramis Lidocaine

Neuramis utilizes patented Stabilized Hyaluronic Acid Particle Engineering (SHAPE) technology to create monophasic HA gel with 92% cross-linking efficiency. The optimized 20mg/ml HA concentration combined with 0.3% lidocaine demonstrates 9-month persistence in 87% of subjects (n=214) per 12-month clinical monitoring. Particle size distribution of 180-250μm ensures optimal tissue integration while maintaining 98.7% product sterility through terminal filtration.

Product Specifications

• Composition: HA 20mg/ml, Lidocaine 0.3%
• Volume: 1.0ml sterile
• : 30G×½” (0.3×13mm)
• Storage: 2-25°C horizontal position
• Shelf Life: 24 months unopened
• CE Certification: Class III Medical Device
• Indications: NLF, perioral lines, lip augmentation
• Injection Depth: Mid-to-deep dermis
• Technique: Linear threading or serial puncture
• Max Volume: 1.5ml per treatment area
• Anesthesia: Not required (pre-incorporated)